Effects of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial)

Authors:
  • JLJan van Lunzen
    Jan van Lunzen
  • MWMichael Westby
    Michael Westby
  • EOEithne O'SUllivan
    Eithne O'SUllivan
  • CSClaus Schneider
    Claus Schneider
  • AAAxel Adam
    Axel Adam
  • LWLutwin Weitner
    Lutwin Weitner
  • BKBirger Kuhlmann
    Birger Kuhlmann
  • CHChristian Hoffmann
    Christian Hoffmann
  • SFStefan Fenske
    Stefan Fenske
  • PAPhilipp S. Aries
    Philipp S. Aries
  • ODOlaf Degen
    Olaf Degen

Abstract
The effect of interleukin-2 (IL-2) in combination with antiretroviral therapy on HIV-1 replication and reservoirs was investigated. In a prospective, open-label trial, 56 asymptomatic HIV-1-infected subjects (CD4 T cell count > 350 × 106 cells/l) were randomized to highly active antiretroviral therapy (HAART: stavudine, lamivudine, nelfinavir, saquinavir) with or without IL-2 (9 megaunits daily for 5 days in 6-weekly intervals for a total of eight cycles). Productive and latent infection were analysed in peripheral blood, and residual virus replication in the lymphoid tissue and in the cerebrospinal fluid. The influence of IL-2 on viral rebound after treatment discontinuation was studied. Virus replication was detected in 21 of 31 on-treatment lymph nodes despite undetectable plasma viraemia. Viral RNA was found in resting as well as in proliferating cells. RNA-negative patients tended towards more rapid proviral DNA elimination. Supplementary IL-2 led to a greater increase in CD4 T cell counts than HAART alone (P < 0.001), resulting in normalization in ~90% of IL-2-treated patients compared with ~50% HAART-only subjects. IL-2 had no beneficial effect on virus replication and on proviral DNA in peripheral blood. Viral persistence during HAART is partly a result of continued low-level replication, calling for more active regimens. IL-2 accelerates the normalization of CD4 T cell counts but does not impact on virus production or latency.

This publication has 41 references indexed in Scilit: